Atkinson Edward Morrow III (CIK 0001914164)

Latest company ownership

ETNB - 89bio, Inc.
Role: Director
Shares held
56,400
Last filed at
Oct 30, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q1 2025Q4
VRTX - VERTEX PHARMACEUTICALS INC / MA
Role: EVP, Chief Technical Ops. Off.
Shares held
16,852
Last filed at
Nov 19, 2025
Confidence Score
29.7
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 17, 2025 Nov 19, 2025 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 20.0 -2,500 -12.92% ✓ $1.1M
Feb 26, 2025 Feb 28, 2025 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 10.0 -5,132 -20.96% ✓ $2.5M
Feb 24, 2025 Feb 26, 2025 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 20.0 -3,423 -12.27% ✓ $1.7M
Feb 14, 2025 Feb 19, 2025 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 20.0 -1,529 -5.19% ✗ $708.6K
Feb 10, 2025 Feb 12, 2025 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 20.0 -2,623 -10.15% ✓ $1.2M
Jun 11, 2024 Jun 13, 2024 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 3.8 -14,112 -46.91% ✓ $6.8M
Feb 23, 2024 Feb 27, 2024 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 20.0 -2,537 -13.71% ✓ $1.1M
Feb 21, 2024 Feb 23, 2024 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 30.0 -1,201 -6.09% ✓ $506.5K
Feb 16, 2024 Feb 21, 2024 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 20.0 -3,427 -14.81% ✓ $1.4M
Feb 9, 2024 Feb 13, 2024 VERTEX PHARMACEUTICALS INC / MA EVP, Chief Technical Ops. Off. Sell 30.0 -1,745 -7.01% ✓ $735.4K
Jun 1, 2023 Jun 5, 2023 89bio, Inc. Director Sell 10.0 -6,250 -100.00% ✓ $111.9K
Mar 1, 2023 Mar 3, 2023 89bio, Inc. Director Sell 10.0 -10,000 -100.00% ✓ $136K